Seminars in Diagnostic Pathology
Volume 25, Issue 4 , Pages 317-322 , November 2008

Biobanking: old activity or young discipline?

  • Manuel M. Morente

      Affiliations

    • Tumor Bank Unit, Molecular Pathology Programme, Spanish National Cancer Center, Madrid, Spain
    • Tumor Bank Unit, Molecular Pathology Programme, Cancer Research Center-IBMCC, University of Salamanca–CSIC, Salamanca, Spain
    • Corresponding Author InformationAddress reprint requests and correspondence: Manuel M. Morente, Tumor Bank Unit, Spanish National Cancer Center, CNIO, Melchor Fernández Almagro, 3, ES–28029 Madrid, Spain
    • ,
  • Pedro L. Fernández

      Affiliations

    • Tumor Bank Unit, Department of Pathology, Hospital Clinic and IDIBAPS, University of Barcelona, Barcelona, Spain
    • Tumor Bank Unit, Molecular Pathology Programme, Cancer Research Center-IBMCC, University of Salamanca–CSIC, Salamanca, Spain
    • ,
  • Enrique de Alava, PhD, MD

      Affiliations

    • Tumor Bank Unit, Molecular Pathology Programme, Spanish National Cancer Center, Madrid, Spain
    • Tumor Bank Unit, Molecular Pathology Programme, Cancer Research Center-IBMCC, University of Salamanca–CSIC, Salamanca, Spain

References 

  1. OECD (ed): Biological Resource Centers: Underpinning the future of life sciences and biotechnology. Paris, OECD, 2001. Available at: http://www.oecd.org/dataoecd/55/48/2487422.pdf
  2. Grizzle W, Woodruff KH, Trainer TD. The pathologist's role in the use of human tissues in research: legal, ethical, and other issues. Arch Pathol Lab Med. 1996;120:909–912
  3. Camí J, Bertranpetit J: The promising future of Biobanks: building a global perspective, in The American Society for Cell Biology (ed): The Genomics Revolution: Reshaping Vaccine Development and Delivery. Bethesda, MD, The American Society for Cell Biology, 2005, pp 119-130
  4. Morente MM, Alonso S. Current challenges of human tumour banking. Hematol Oncol. 2005;23:54–56
  5. Balfour–Sartor R. Translational research: bridging the widening gap between basic and clinical research. Gastroenterology. 2003;124:1178
  6. Ioannidis JPA. Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med. 2004;2:5–10
  7. Oosterhuis JW, Coebergh JW, van Veen EB. Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer. 2003;3:73–77
  8. Foster MW, Sharp RR. Will investments in large-scale prospective cohorts and biobanks limit our ability to discover weaker, less common genetic and environmental contributors to complex diseases?. Environ Health Perspect. 2005;113:119–122
  9. Taubenberger JK, Reid AH, Krafft AE, et al. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science. 1997;275:1793–1796
  10. Ozols RF, Herbst RS, Colson YL, et al. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening: a report from the American Society of Clinical Oncology. J Clin Oncol. 2007;25:146–162
  11. Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. J Am Med Assoc. 2001;285:540–544
  12. Naber SP. Continuing role of a frozen-tissue bank in molecular pathology. Diagn Mol Pathol. 1996;5:253–259
  13. NCI Best Practices for Specimen Resources. Bethesda, MD, NCI, 2007. Available at. http://biospecimens.cancer.gov/global/pdfs/NCI_Best_Practices_060507.pdf
  14. Cambon–Thomsen A, Ducournau1 P, Gourraud PA, et al. Biobanks for genomics and genomics for Biobanks. Comp Funct Genom. 2003;4:628–634
  15. Cambon–Thomsen A, Rial–Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J. 2007;30:373–382
  16. Vaught JB, Lockhart N, Thiel KS, et al. Ethical, legal, and policy issues: dominating the biospecimen discusión. Cancer Epidemiol Biomarkers Prev. 2007;16:2521–2523
  17. van Veen EB, Riegman PH, Dinjens WN, et al. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer. 2006;42:2914–2923
  18. Adam D. Online tumour bank aims to offer ready route to tissues. Nature. 2002;416:464
  19. Morente MM, de Alava E, Fernandez PL. Tumour banking: the Spanish design. Pathobiology. 2007;74:245–250
  20. In:  Caboux E,  Plymoth A,  Hainaut P editor. International Network of Biological Resource Centers for Cancer Research: Recommendations on Common Minimal Technical Standards. Lyon: IARC/WHO; 2007;Available at: http://www.iarc.fr/IARCPress/pdfs/standardsBRC/Standards_ProtocolsBRC.pdf
  21. International Society for Biological and Environmental Repositories (ISBER). 2008 Best Practices for Repositories: collection, storage, retrieval and distribution of biological materials for research. Cell Preserv Technol. 2008;6:3–58Available at: http://www.isber.org/Pubs/BestPractices2008.pdf
  22. P3G: Public Population Project in Genomics. Available at: http://www.p3gconsortium.org
  23. OECD (ed): OECD Best Practice Guidelines for Biological Resource Centers: General Best Practice Guidelines for all BRCs. Paris, OECD, 2007. Available at: http://www.oecd.org/dataoecd/7/13/38777417.pdf
  24. Mager SR, Oomen MHA, Morente MM, et al. Standard operating procedure for the collection of fresh frozen tissue samples. Eur J Cancer. 2007;43:828–834
  25. Morente MM, Mager R, Alonso S, et al. TuBaFrost 2: standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer. 2006;42:2684–2691
  26. Betsou F, Luzergues A, Carter A, et al. Critical compilation of existing guidelines for research biobanks against an ISO accreditation scheme. Qual Assur J. 2008;(in press)
  27. Marincola FM. Translational medicine: a two-way road. J Transl Med. 2003;1:1–2
  28. Zerhouni EA. Translational and clinical science: time for a new vision. N Engl J Med. 2005;353:1621–1623
  29. University of Pittsburgh. IRB guidance on research limited to retrospective medical record reviews, 2005. Available at: http://www.irb.pitt.edu
  30. Cambon–Thomsen A. The social and ethical issues of post-genomic human biobanks. Nat Rev Genet. 2004;5:866–873
  31. Hansson MG. For the safety and benefit of current and future patients. Pathobiology. 2007;74:198–205
  32. Glantz L, Roche P, Annas GJ. Rules for donations to tissue banks: what next?. N Engl J Med. 2008;358:298–303
  33. Bryant RJ, Harrison RF, Start RD, et al. Ownership and uses of human tissue: what are the opinions of surgical in-patients?. J Clin Pathol. 2008;61:322–326
  34. Salvaterra E, Lecchi L, Giovanelli S, et al. Banking together: a unified model of informed consent for biobanking. EMBO Rep. 2008;9:307–313
  35. Helgesson G, Dillner J, Carlson J, et al. Ethical framework for previously collected biobank simples. Nat Biotechnol. 2007;25:973–976
  36. Homan R. The principle of assumed consent: the ethics of gatekeeping. J Philos Educ. 2001;35:329–343
  37. Lunshof JE, Chadwick R, Vorhaus DB, et al. From genetic privacy to open consent. Nat Rev Genet. 2008;9:406–411
  38. Maschke KJ. Alternative consent approaches for biobank research. Lancet Oncol. 2006;7:193–194
  39. van Diese PJ. No consent should be needed for using leftover body material for scientific purposes. Br Med J. 2002;325:648–650
  40. Wendler D. One-time general consent for research on biological samples. Br Med J. 2006;332:544–547
  41. Andanda PA. Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries. J Med Ethics. 2008;34:171–179
  42. Hoeyer K, Olofsson BO, Mjörndal T, et al. The ethics of research using biobanks: reason to question the importance attributed to informed consent. Arch Intern Med. 2005;165:97–100
  43. Hansson MG, Dillner J, Bartram CR, et al. Should donors be allowed to give broad consent to future biobank research?. Lancet Oncol. 2006;7:266–269
  44. Riegman PH, Dinjens WN, Oomen MH, et al. TuBaFrost 1: uniting local frozen tumour banks into a European network: an overview. Eur J Cancer. 2006;42:2678–2683
  45. Riegman PH, Oomen MH, Dinjens WN, et al. TuBaFrost: European virtual tumor tissue banking. Adv Exp Med Biol. 2006;587:65–74
  46. Wales Cancer Bank. Available at. http://www.walescancerbank.com/confed.html
  47. Biobank Ireland. Available at. http://www.biobankireland.com
  48. Schmitz G, Aslanidis C, Liebisch G, et al. The Danubian Biobank Project. Stud Health Technol Inform. 2008;134:143–159

PII: S0740-2570(08)00061-0

doi: 10.1053/j.semdp.2008.07.007

Seminars in Diagnostic Pathology
Volume 25, Issue 4 , Pages 317-322 , November 2008

Article Tools